Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion type Assertion NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_head.
- NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion wasGeneratedBy ECO_0000203 NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_provenance.
- NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion wasDerivedFrom befree-20140225 NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_provenance.
- NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion SIO_000772 11927838 NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_provenance.
- NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion evidence source_evidence_literature NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_provenance.
- NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_assertion description "[Statistically significant increases in asthma risk were also observed among the whole study population for the concurrent presence of the GSTM1 null genotype and either NAT1 (odds ratio [OR] 4.53, 95% CI 1.76 to 11.6) or NAT2 (OR 3.12, 95% CI 1.11 to 8.78) slow acetylator genotypes, and of NAT1 and NAT2 slow acetylator genotypes (OR 4.20, 95% CI 1.51 to 11.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438129.RAHd3pL6KC-CJfGYMwXv0jqnF13UZwQGjweSKAz1TOlmU130_provenance.